The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Fleming Nigel since 2009.
The trader's CIK number is 1245365.
At the time of the last reporting, Fleming Nigel was the Director of Impax Laboratories Inc. (stock ticker symbol IPXL).
Also see all insider trading activities at Impax Laboratories Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | IPXL | 0 | $0 | 29,166 | $1,196,389 | 23,000 | $453,790 |
| 2014 | IPXL | 0 | $0 | 7,233 | $189,663 | 0 | $0 |
| 2013 | IPXL | 0 | $0 | 18,000 | $282,660 | 18,000 | $117,900 |
| 2012 | IPXL | 0 | $0 | 24,667 | $590,367 | 18,000 | $117,900 |
| 2011 | IPXL | 0 | $0 | 27,974 | $591,627 | 8,000 | $52,400 |
| 2010 | IPXL | 0 | $0 | 25,360 | $468,877 | 24,000 | $160,087 |
| 2009 | IPXL | 0 | $0 | 4,000 | $30,768 | 4,000 | $16,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-31 | IPXL | Sale | 29,166 | 41.02 | 1,196,389 |
| 2015-08-31 | IPXL | Option Ex | 23,000 | 19.73 | 453,790 |
| 2014-05-16 | IPXL | Sale | 1,900 | 25.72 | 48,868 |
| 2014-05-12 | IPXL | Sale | 1,333 | 26.58 | 35,435 |
| 2014-05-06 | IPXL | Sale | 4,000 | 26.34 | 105,360 |
| 2013-04-08 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2013-04-08 | IPXL | Sale | 6,000 | 16.20 | 97,200 |
| 2013-04-01 | IPXL | Sale | 6,000 | 15.31 | 91,860 |
| 2013-04-01 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2013-03-25 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2013-03-25 | IPXL | Sale | 6,000 | 15.60 | 93,600 |
| 2012-08-27 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2012-08-27 | IPXL | Sale | 6,000 | 23.92 | 143,520 |
| 2012-08-13 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2012-08-20 | IPXL | Option Ex | 6,000 | 6.55 | 39,300 |
| 2012-08-20 | IPXL | Sale | 6,000 | 23.99 | 143,940 |
| 2012-08-13 | IPXL | Sale | 6,000 | 23.91 | 143,460 |
| 2012-08-06 | IPXL | Sale | 6,667 | 23.92 | 159,447 |
| 2011-09-01 | IPXL | Sale | 14,640 | 19.04 | 278,745 |
| 2011-06-07 | IPXL | Option Ex | 8,000 | 6.55 | 52,400 |
| 2011-06-07 | IPXL | Sale | 13,334 | 23.46 | 312,882 |
| 2010-12-09 | IPXL | Sale | 8,500 | 18.70 | 158,950 |
| 2010-12-09 | IPXL | Option Ex | 8,500 | 7.28 | 61,837 |
| 2010-08-10 | IPXL | Option Ex | 7,500 | 7.10 | 53,250 |
| 2010-08-10 | IPXL | Sale | 7,500 | 16.83 | 126,224 |
| 2010-06-04 | IPXL | Sale | 1,360 | 20.37 | 27,703 |
| 2010-05-17 | IPXL | Option Ex | 8,000 | 5.62 | 45,000 |
| 2010-05-17 | IPXL | Sale | 8,000 | 19.50 | 156,000 |
| 2009-08-14 | IPXL | Option Ex | 4,000 | 4.00 | 16,000 |
| 2009-08-14 | IPXL | Sale | 4,000 | 7.69 | 30,768 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fleming Nigel (Director of Impax Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.